Tenon Medical, Inc. (TNON) — Financial statements
Income statement, balance sheet, and cash flow for Tenon Medical, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 4↑20.4% | 3↑11.9% | 3↑323.7% | 0.69↑331.9% | 0.16 | |
| Cost of Revenue | 2↑1.3% | 2↓7.2% | 2↑26.7% | 1↑2321.8% | 0.06 | |
| Gross Profit | 2↑37.8% | 2↑37.9% | 1↑293.6% | -0.64↓710.5% | 0.11 | |
| Operating Expenses | ||||||
| R&D Expenses | 2↓17.4% | 3↓17.7% | 3↑11.8% | 3↑64.6% | 2 | |
| General & Administrative Expenses | 7↓10.2% | 8↑10.5% | 7↓5.3% | 7↑174.2% | 3 | |
| Selling & Marketing Expenses | 6↑17.9% | 5↓24.6% | 7↓13.5% | 8↑265.9% | 2 | |
| SG&A Expenses | 13↑1.0% | 13↓6.7% | 14↓9.5% | 15↑214.7% | 5 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 15↓2.1% | 15↓8.8% | 17↓6.2% | 18↑175.4% | 7 | |
| Total Costs & Expenses | 17↓1.8% | 17↓8.6% | 19↓3.9% | 19↑193.2% | 7 | |
| Operating Results | ||||||
| Operating Income | -13↑7.1% | -14↑12.5% | -16↑16.0% | -19↓189.8% | -6 | |
| Depreciation & Amortization | 0.00↓100.0% | 0.66↑53.8% | 0.43↑47.4% | 0.29↑153.5% | 0.11 | |
| EBITDA | -13↑1.5% | -13↑14.2% | -15↑17.2% | -18↓188.0% | -6 | |
| EBIT | -13↑6.2% | -14↑12.3% | -16↑16.2% | -19↓187.4% | -6 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.00↑100.0% | -0.03↓61.9% | -0.02↑94.1% | -0.35↑43.0% | -0.62 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 0.00↓100.0% | 0.03↑61.9% | 0.02↓94.1% | 0.35↓43.0% | 0.62 | |
| Non-Operating Income | 0.00↑100.0% | -0.13↑24.0% | -0.17↓3.1% | -0.16↓16100.0% | -0.00 | |
| Other Income / Expenses | 0.24↑153.8% | 0.09↓36.3% | 0.15↑176.0% | -0.19↑69.0% | -0.62 | |
| Income Before Tax | -13↑8.2% | -14↑12.2% | -16↑17.6% | -19↓167.2% | -7 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -13↑8.2% | -14↑12.2% | -16↑17.6% | -19↓167.2% | -7 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -13↑8.2% | -14↑12.2% | -16↑17.6% | -19↓168.4% | -7 | |
| Bottom-Line Net Income | -13↑8.2% | -14↑12.2% | -16↑17.6% | -19↓168.4% | -7 | |
| EPS (Basic) | -1.70↑84.9% | -11.26↑83.6% | -68.64↑63.4% | -187.30↑70.0% | -624.38 | |
| EPS (Diluted) | -1.70↑84.9% | -11.26↑83.6% | -68.64↑63.4% | -187.30↑70.0% | -624.38 | |
| Weighted Average Shares | 7↑508.2% | 1↑434.8% | 0.23↑124.8% | 0.10↑794.8% | 0.01 | |
| Weighted Average Diluted Shares | 7↑508.2% | 1↑434.8% | 0.23↑124.8% | 0.10↑794.8% | 0.01 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.